In-Vitro Diagnostics Market

In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) - Global Forecast to 2025

Report Code: MD 3609 Nov, 2020, by marketsandmarkets.com

[ 359 Pages Report] The global in vitro diagnostics market size is projected to reach USD 96.0 billion by 2025 from USD 84.5 billion in 2020, at a CAGR of 2.6%. The rising demand for POC IVD devices has positively impacted the growth of the global IVD market. The recently launched IVD instruments/devices are convenient to use and highly efficient, which has increased their adoption among healthcare professionals. Also, several over-the-counter diagnostic products, such as glucose monitoring kits, are available in the market. These products are mainly preferred by the elderly to reduce hospital visits. The importance of these products has increased during the COVID-19 pandemic, as people are opting for convenient diagnostic tests that can be performed in home care settings. These factors, coupled with the increasing prevalence of chronic diseases such as cancer and diabetes, increasing awareness about disease diagnosis, and the growing disposable income levels are expected to support the growth of this market.

Global In-vitro Diagnostics Market Trends

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the IVD market: 

The IVD market includes major Tier I and II suppliers like Roche Diagnostics, Abbott Laboratories and Siemens Healthineers. These suppliers have their manufacturing facilities spread across various countries across Asia Pacific, Europe, North America, South America, and RoW. COVID-19 has impacted their businesses as well.  The companies started introducing rapid diagnostic tests to sustain market competition.

  • In September 2020, Roche launched SARS-CoV-2 antibody test that is highly efficient and provides quick result. Launch of such highly efficient tests has fostered company’s growth to some extent during the pandemic Covid-19.
  • In September 2020, Sysmex Corporation introduced antigen detecting reagent for Covid-19 virus. Introducing such superior quality reagents has positively impacted the company’s revenue generation. 

In-vitro Diagnostics Market Dynamics: 

Driver: Rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases 

The increasing geriatric population in developed as well as developing regions will positively influence the growth of the IVD market. With the rapid growth in the geriatric population globally, the prevalence of age associated diseases is expected to increase significantly. According to the OECD, the number of elderly people living in the US was ~54 million in 2019. Other developed economies around the world also have large and growing geriatric populations. For instance, the ratio of the elderly population to the productive population is the highest in Japan, followed by Germany. The total population of Japan is around 126 million, with the elderly accounting for over 28% of this population. In Germany, the geriatric population accounts for around 21% of the country’s population. 

With age, the risk of developing diseases increases proportionately—for instance, nearly 80% of the elderly population in the US suffers from one chronic condition (Source: Centers for Disease Control and Prevention). 

It is estimated that 60% of individuals aged 65 years or older will be living with more than one chronic condition by 2030 (Source: American Medical Association). Pneumonia is one of the fatal infectious diseases that affect the elderly population in the age group of 60 years and above. In European countries, mortality in the elderly is high due to pneumonia. The disease is not only prevalent in European countries but also affects large populations globally. For instance, according to the American Thoracic Society, around 1 million individuals in the US seek medical care for pneumonia. Diabetes is another chronic disease that affects the geriatric population since this population is prone to endocrine disorders due to hormonal imbalance. According to the International Journal of Health Policy and Management, China is one of the countries with the highest prevalence of diabetes. Around 114 million people in China suffer from diabetes. Similar is the condition in other developed as well as developing economies. 

The growth in the geriatric population is expected to increase the prevalence of various diseases across the globe. This is considered as a key factor driving the growth of the IVD market. 

Restraint: Unfavorable reimbursement scenario 

Inadequate reimbursement is a major factor restraining the growth of the IVD market. In the US, Medicare revised its reimbursement mechanism for some IVD tests, including molecular tests, a few years back. Some of these molecular pathology tests do not have their own Healthcare Common Procedure Coding System (HCPCS) codes and are instead billed using unlisted codes. In such cases, Medicare Administrative Contractors (MACs) establish a payment amount for their local jurisdictions. According to CMS, approximately 75% of tests showed reductions in reimbursement rate from January 2017. Some of these tests include molecular tests, targeted NGS analysis panels of five to 50 genes, and cancer tests. These developments are expected to adversely affect the US molecular and genetic testing market, which will hinder the growth of the IVD market. 

Opportunity: Development of condition-specific markers and tests 

Biomarkers have gained significant clinical value and interest in the medical industry, as they are very useful in the screening, diagnosis, and treatment of diseases. In the diagnosis process, markers can determine staging, grading, and selection of the initial therapy. During treatments, they can be used to monitor therapy, select additional therapies, or monitor recurrent diseases. Technological advancements in genomics, proteomics, and molecular pathology have helped introduce new biomarkers with potential clinical value. The integration of biomarkers and the availability of biomolecular tools are expected to help in the development of a new range of condition-specific tests, thus creating new opportunities for the IVD market. 

Challenge: Changing regulatory landscape 

Regulatory and legal requirements applied to IVD in the US and European countries are becoming more stringent. In the US, IVD products are defined under 21 CFR 809 and regulated under guidelines similar to medical devices. The FDA released new FDA guidance documents. Under US federal regulations, device manufacturers are required to submit a 510(k) application for any further modifications to a device. New applications may be required for software updates to, or new software installation in, an existing device or for any other changes made to these devices.  

In the EU, IVD products are defined and regulated separately from other medical devices under a separate IVD Directive 98/79/EC. IVD devices must comply with the essential requirements of Annex 1 of the directive, and products must be CE-marked to be legally marketed in the EU. New regulations are expected to replace earlier EU directives and add stringent requirements for the CE Marking of new and existing devices. By May 26, 2020, any new medical device certified in the EU must comply with the new requirements of the Medical Device Regulation (MDR). By May 26, 2022, any new IVD device must be certified under the new In Vitro Diagnostic Device Regulation (IVDR). In 2024, any device sold, and in 2025, any device put into service, must comply with the new regulations 

The kits and reagents segment is projected to grow at the highest CAGR during the forecast period 

Within the product and services segment, the market is segmented into reagents and kits, instruments, data management software and services. Kist and reagents segment are expected to have high CAGR and the high growth rate can be attributed to the positive impact of Covid-19 on the demand for IVD products. Occurrence of pandemic Covid-19 has raised the demand for reagents and kits that offer speedy diagnosis and helps to combat the fatal consequences of the virus. Also, recently developed reagents and kits possess high precision and enable accurate diagnosis. Aforementioned factors have escalated the segmental growth during the forecast timeframe.

Hospitals hold the largest share in the market 

Based on the end user, the market is broadly classified into hospital laboratories, laboratories, academics, point-of-care testing, patient self-testing and others. Hospital laboratories hold the largest share in the market. The largest share of this segment in the market can be attributed to the tremendous amount of diagnostic testing required to support a clinical decision enhancing patient recovery. 

In-vitro Diagnostics Market Ecosystem

In-Vitro Diagnostics Market Ecosystem

To know about the assumptions considered for the study, download the pdf brochure

North America held the largest share in the in vitro diagnostics market in 2019. This dominance of North America in this market is due to the presence of many diagnostic companies, high investments and rising focus on the PoC and molecular diagnostic devices, and high allocation to R&D. The Asia Pacific market is expected to register the highest growth during the forecast period, primarily due to the rising affordability rates and improving regulatory scenario. 

In-Vitro Diagnostics Market By Region

Key Market Players 

The prominent players in the global in vitro diagnostics market are Roche Diagnostics Limited (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific (US), Johnson & Johnson (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMérieux (France), Diasorin (Italy), Ortho-Clinical Diagnostics (US), and Qiagen (Germany).

Scope of the Report: 

Report Metric

Details

Market size available for years

2018–2025

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD Billion)

Segments covered

Product and services, technology, application, end user, and region

Geographies covered

North America, Europe, APAC, Latin America, and the Middle East & Africa

Companies Covered

Roche Diagnostics Limited (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific (US), Johnson & Johnson (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMérieux (France), Diasorin (Italy), Ortho-Clinical Diagnostics (US), and Qiagen (Germany).

The research report categorizes the market into the following segments and subsegments: 

By Product & services

  • Instruments
    • Fully-automated Instruments
    • Semi-automated Instruments
    • Others
  • Reagents & kits
  • Data Management Software
  • Services 

By Technology

  • Immunochemistry/Immunoassay
    • Enzyme-Linked Immunosorbent Assay (ELISA)
      • Chemiluminescence Immunoassay (CLIA)
      • Fluorescence Immunoassay (FIA)
      • Colorimetric Immunoassay (CI)
    • Radioimmunoassays (RIA)
    • Rapid Tests
    • Western Blot
    • ELISPOT
  • Clinical Chemistry
    • Basic Metabolic Panel
    • Electrolyte Panel
    • Liver Panel
    • Lipid Profile
    • Renal Profile
    • Thyroid Function Panel
    • Specialty Chemicals
  • Molecular Diagnostics
    • Polymerase Chain Reaction (PCR)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Hybridization (In-situ Hybridization & FISH)
    • DNA Sequencing & NGS
    • Microarray
    • Others
  • Microbiology
  • Hematology
  • Coagulation & Hemostasis
  • Urinalysis
  • Others 

By Application

  • Diabetes
  • Infectious Diseases
  • Oncology/Cancer
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing/Pharmacogenomics
  • HIV/AIDS
  • Others

By End-user

  • Laboratories
    • Large/Reference Laboratories
    • Medium-sized Laboratories
    • Small Laboratories
  • Hospitals
  • Academics
  • Point-Of-Care Testing
  • Patient Self-Testing
  • Others

By Region: 

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa 

Recent Developments

  • In September 2020, Sysmex applied for marketing & manufacturing approval for a SARS-CoV-2 antigen detection reagent. Introduction of new products has positively impacted company’s growth.
  • In September 2020, Roche Diagnostics Launched SARS-CoV-2 antibody test. Introduction of new products has fostered company’s growth to some extent. Launch of antigen tests amidst pandemic has favored company’s growth.
  • In July 2020, Sysmex launched the Oncoguide panel system, which supports cancer genome profiling. Addition of new products has fostered the company’s growth to some extent. 

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 35)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKET SCOPE
           1.3.1 INCLUSIONS AND EXCLUSIONS
    1.4 MARKETS COVERED
    1.5 YEARS CONSIDERED FOR THE STUDY
    1.6 CURRENCY
        TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
    1.7 LIMITATIONS
    1.8 STAKEHOLDERS
    1.9 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 39)
    2.1 RESEARCH APPROACH
           2.1.1 RESEARCH DESIGN
           2.1.2 SECONDARY RESEARCH
                    2.1.2.1 Key data from secondary sources
           2.1.3 PRIMARY RESEARCH
           2.1.4 PRIMARY SOURCES
                    2.1.4.1 Key data from primary sources
                    2.1.4.2 Breakdown of Primaries
                            FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
                            FIGURE 3 SUPPLY SIDE ANALYSIS: IVD MARKET (2019)
                            FIGURE 4 DEMAND SIDE APPROACH: RAPID TEST MARKET SIZE (2019)
                            FIGURE 7 CAGR PROJECTIONS FROM THE ANALYSIS OF MARKET DRIVERS, RESTRAINTS< OPPORTUNITIES & CHALLENGES OF THE IVD INDUSTRY (2019-2025)
    2.6 COVID-19 HEALTH ASSESSMENT
    2.7 COVID-19 ECONOMIC ASSESSMENT
    2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO

3 EXECUTIVE SUMMARY (Page No. - 54)
  FIGURE 11 IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,  2020 VS. 2025 (USD MILLION)
  FIGURE 12 IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,  2020 VS. 2025 (USD MILLION)
  FIGURE 13 IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,  2020 VS. 2025 (USD MILLION)
  FIGURE 14 IN VITRO DIAGNOSTICS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
  FIGURE 15 GEOGRAPHIC SNAPSHOT OF THE IN VITRO DIAGNOSTICS MARKET

4 PREMIUM INSIGHTS (Page No. - 58)
    4.1 IN VITRO DIAGNOSTICS MARKET OVERVIEW
        FIGURE 16 RISING INCIDENCE OF CHRONIC & INFECTIOUS DISEASES IS DRIVING THE GROWTH OF THE IN VITRO DIAGNOSTICS MARKET
    4.2 ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET,  BY PRODUCT & SERVICE AND COUNTRY (2019)
    4.3 IN VITRO DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
        FIGURE 17 THE MARKET IN CHINA IS PROJECTED TO REGISTER THE HIGHEST CAGR IN THE IN VITRO DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
    4.4 GEOGRAPHIC MIX: IN VITRO DIAGNOSTICS MARKET
        FIGURE 18 APAC TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
    4.5 IN VITRO DIAGNOSTICS MARKET: DEVELOPED VS. DEVELOPING MARKETS
        FIGURE 19 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 62)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
        FIGURE 20 IN VITRO DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases
                            TABLE 2 ESTIMATED INCREASE IN THE GERIATRIC POPULATION, BY REGION (2019-2050)
                    5.2.1.2 Increasing adoption of fully automated and POC instruments in developed regions
                    5.2.1.3 Growing awareness regarding disease diagnosis in developing regions
                    5.2.1.4 Growing R&D investments by industry players to launch new IVD products
           5.2.2 RESTRAINTS
                    5.2.2.1 Unfavorable reimbursement scenario
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Development of condition-specific markers and tests
                            TABLE 3 NEW TESTS LAUNCHED BY KEY PLAYERS
                    5.2.3.2 Growing significance of companion diagnostics
                    5.2.3.3 Growth opportunities in emerging countries
           5.2.4 CHALLENGES
                    5.2.4.1 Changing regulatory landscape
                    5.2.4.2 Operational barriers faced in conducting diagnostic tests
           5.2.5 IMPACT OF COVID-19 ON THE IVD MARKET

6 INDUSTRY INSIGHTS (Page No. - 70)
    6.1 INTRODUCTION
    6.2 PORTER'S FIVE FORCES ANALYTICAL FRAMEWORK
    6.3 PESTLE ANALYSIS
    6.4 INDUSTRY ECOSYSTEM ANALYSIS
    6.5 INDUSTRY TRENDS
           6.5.1 AUTOMATION OF CLINICAL LABORATORY TECHNIQUES
           6.5.2 MICROFLUIDICS-BASED POC AND LAB-ON-A-CHIP DIAGNOSTIC DEVICES FOR LABORATORY TESTING
           6.5.3 GROWING NUMBER OF REAGENT RENTAL AGREEMENTS
    6.6 REGULATORY OVERVIEW
           6.6.1 US
                 TABLE 4 US: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
                 FIGURE 21 US: REGULATORY PROCESS FOR IVD DEVICES
           6.6.2 CANADA
                 FIGURE 22 CANADA: REGULATORY PROCESS FOR IVD DEVICES IN CANADA
           6.6.3 EUROPE
                 TABLE 5 EUROPE: CLASSIFICATION OF IVD DEVICES
                 FIGURE 23 EUROPE: REGULATORY PROCESS FOR IVD DEVICES
           6.6.4 JAPAN
                 FIGURE 24 REGULATORY PROCESS FOR IVD DEVICES IN JAPAN
                 TABLE 6 JAPAN: CLASSIFICATION OF IVD REAGENTS CLASSIFICATION OF IVD REAGENTS IN JAPAN
                 TABLE 7 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
           6.6.5 CHINA
                 TABLE 8 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
           6.6.6 INDIA
                 FIGURE 25 INDIA: REGULATORY PROCESS FOR IVD DEVICES
           6.6.7 INDONESIA
                 TABLE 9 INDONESIA: REGISTRATION PROCESS FOR IVD DEVICES
           6.6.8 RUSSIA
                 TABLE 10 RUSSIA: CLASSIFICATION OF IVD DEVICES
           6.6.9 SAUDI ARABIA
                 TABLE 11 SAUDI ARABIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
           6.6.10 MEXICO
                 FIGURE 26 MEXICO: REGULATORY PROCESS FOR IVD DEVICES
                 TABLE 12 MEXICO: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
           6.6.11 BRAZIL
                 FIGURE 27 BRAZIL: REGULATORY PROCESS FOR IVD DEVICES
           6.6.12 SOUTH KOREA
                 TABLE 13 SOUTH KOREA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    6.7 VENDOR BENCHMARKING
        TABLE 14 IN VITRO DIAGNOSTIC PRODUCTS & SERVICES MARKET: PRODUCT PORTFOLIO ANALYSIS

7 IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE (Page No. - 88)
    7.1 INTRODUCTION
        TABLE 15 IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    7.2 REAGENTS & KITS
        TABLE 16 IVD REAGENTS & KITS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
        TABLE 17 IVD REAGENTS & KITS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    7.3 INSTRUMENTS
        TABLE 18 IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 19 IVD INSTRUMENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
        TABLE 20 IVD INSTRUMENTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
           7.3.1 SEMI-AUTOMATED INSTRUMENTS
                 TABLE 21 SEMI-AUTOMATED IVD INSTRUMENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
           7.3.2 FULLY AUTOMATED INSTRUMENTS
                 TABLE 22 MAJOR LAB AUTOMATION SYSTEMS & FULLY AUTOMATED INSTRUMENTS IN THE MARKET
                 TABLE 23 FULLY AUTOMATED IVD INSTRUMENTS MARKET, BY COUNTRY,  2018-2025 (USD MILLION)
           7.3.3 OTHER INSTRUMENTS
                 TABLE 24 OTHER IVD INSTRUMENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    7.4 SERVICES
        FIGURE 28 TYPES OF IN VITRO DIAGNOSTIC SERVICES
        TABLE 25 IVD SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
        TABLE 26 IVD SERVICES MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    7.5 DATA MANAGEMENT SOFTWARE
        TABLE 27 KEY DATA MANAGEMENT SOFTWARE SOLUTIONS AVAILABLE IN THE MARKET
        TABLE 28 IVD DATA MANAGEMENT SOFTWARE MARKET, BY COUNTRY,  2018-2025 (USD MILLION)
        TABLE 29 IVD DATA MANAGEMENT SOFTWARE MARKET, BY TECHNOLOGY,  2018-2025 (USD MILLION)

8 IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY (Page No. - 102)
    8.1 INTRODUCTION
        TABLE 30 IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    8.2 IMMUNOASSAY/IMMUNOCHEMISTRY
        TABLE 31 IMMUNOASSAY/IMMUNOCHEMISTRY ANALYZERS AVAILABLE IN THE MARKET
        TABLE 32 IMMUNOASSAY/IMMUNOCHEMISTRY MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 33 IMMUNOASSAY/IMMUNOCHEMISTRY MARKET, BY COUNTRY,  2018-2025 (USD MILLION)
           8.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAYS
                 TABLE 34 ELISA ANALYZERS AVAILABLE IN THE MARKET
                 TABLE 35 ENZYME-LINKED IMMUNOSORBENT ASSAYS MARKET, BY COUNTRY,  2018-2025 (USD MILLION)
                 TABLE 36 ENZYME-LINKED IMMUNOSORBENT ASSAYS MARKET, BY TYPE,  2018-2025 (USD MILLION)
                    8.2.1.1 Chemiluminescence immunoassays
                            TABLE 37 CHEMILUMINESCENCE IMMUNOASSAY SYSTEMS AVAILABLE IN THE MARKET
                            TABLE 38 CHEMILUMINESCENCE IMMUNOASSAYS MARKET, BY COUNTRY,  2018-2025 (USD MILLION)
                    8.2.1.2 Fluorescence immunoassays
                            TABLE 39 FLUORESCENCE IMMUNOASSAYS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
                    8.2.1.3 Colorimetric immunoassays
                            TABLE 40 COLORIMETRIC IMMUNOASSAYS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
           8.2.2 RADIOIMMUNOASSAYS
                 TABLE 41 RADIOIMMUNOASSAYS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
           8.2.3 RAPID TESTS
                 TABLE 42 RAPID TESTS AVAILABLE IN THE MARKET
                 TABLE 43 RAPID TESTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
           8.2.4 WESTERN BLOTTING
                 TABLE 44 WESTERN BLOTTING SYSTEMS AVAILABLE IN THE MARKET
                 TABLE 45 WESTERN BLOTTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
           8.2.5 ENZYME-LINKED IMMUNOSPOT ASSAYS
                 TABLE 46 ELISPOT ASSAYS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    8.3 CLINICAL CHEMISTRY
                 TABLE 47 CLINICAL CHEMISTRY ANALYZERS FOR HIGH- AND MID-VOLUME LABORATORIES
                 TABLE 48 CLINICAL CHEMISTRY ANALYZERS FOR LOW-VOLUME LABORATORIES
                 TABLE 49 BLOOD GAS ANALYZERS AVAILABLE IN THE MARKET
                 TABLE 50 CLINICAL CHEMISTRY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
                 TABLE 51 CLINICAL CHEMISTRY MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
           8.3.1 BASIC METABOLIC PANELS
                 TABLE 52 BASIC METABOLIC PANELS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
           8.3.2 LIVER PANELS
                 TABLE 53 LIVER PANELS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
           8.3.3 RENAL PROFILES
                 TABLE 54 RENAL PROFILES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
           8.3.4 LIPID PROFILES
                 TABLE 55 LIPID PROFILES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
           8.3.5 THYROID FUNCTION PANELS
                 TABLE 56 THYROID FUNCTION PANELS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
           8.3.6 ELECTROLYTE PANELS
                 TABLE 57 ELECTROLYTE PANELS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
           8.3.7 SPECIALTY CHEMICAL TESTS
                 TABLE 58 SPECIALTY CHEMICAL TESTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    8.4 MOLECULAR DIAGNOSTICS
        TABLE 59 AUTOMATED MOLECULAR DIAGNOSTIC PLATFORMS AVAILABLE IN THE MARKET
        TABLE 60 MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
        TABLE 61 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
           8.4.1 POLYMERASE CHAIN REACTION
                 TABLE 62 PCR INSTRUMENTS AVAILABLE IN THE MARKET
                 TABLE 63 POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
           8.4.2 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY
                 TABLE 64 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY,  2018-2025 (USD MILLION)
           8.4.3 HYBRIDIZATION
                 TABLE 65 HYBRIDIZATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
           8.4.4 DNA SEQUENCING & NEXT-GENERATION SEQUENCING
                 TABLE 66 NGS INSTRUMENTS AVAILABLE IN THE MARKET
                 TABLE 67 DNA SEQUENCING & NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY,  2018-2025 (USD MILLION)
           8.4.5 MICROARRAYS
                 TABLE 68 MICROARRAYS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
           8.4.6 OTHER MDX TECHNOLOGIES
                 TABLE 69 OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY,  2018-2025 (USD MILLION)
    8.5 HEMATOLOGY
        TABLE 70 HEMATOLOGY ANALYZERS AVAILABLE IN THE MARKET
        TABLE 71 HEMATOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    8.6 MICROBIOLOGY
        TABLE 72 MICROBIOLOGY INSTRUMENTS AVAILABLE IN THE MARKET
        TABLE 73 MICROBIOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    8.7 COAGULATION & HEMOSTASIS
        TABLE 74 COAGULATION ANALYZERS AVAILABLE IN THE MARKET
        TABLE 75 POINT-OF-CARE/SELF-MONITORING COAGULATION ANALYZERS  AVAILABLE IN THE MARKET
        TABLE 76 COAGULATION & HEMOSTASIS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    8.8 URINALYSIS
        TABLE 77 URINALYSIS INSTRUMENTS AVAILABLE IN THE MARKET
        TABLE 78 URINALYSIS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    8.9 OTHER TECHNOLOGIES
        TABLE 79 BLOOD GLUCOSE TESTING SYSTEMS AVAILABLE IN THE MARKET
        TABLE 80 TISSUE PROCESSORS, EMBEDDERS, MICROTOMES, AND STAINERS  AVAILABLE IN THE MARKET
        TABLE 81 OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)

9 IN VITRO DIAGNOSTICS MARKET, BY APPLICATION (Page No. - 154)
    9.1 INTRODUCTION
        TABLE 82 IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    9.2 INFECTIOUS DISEASES
        TABLE 83 IVD MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
    9.3 DIABETES
        TABLE 84 GLOBAL DIABETIC PATIENT POPULATION, 2019 VS. 2030 (MILLION)
        TABLE 85 IVD MARKET FOR DIABETES, BY COUNTRY, 2018-2025 (USD MILLION)
    9.4 ONCOLOGY
        TABLE 86 IVD MARKET FOR ONCOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
    9.5 CARDIOLOGY
        TABLE 87 IVD MARKET FOR CARDIOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
    9.6 DRUG TESTING/PHARMACOGENOMICS
        TABLE 88 IVD MARKET FOR DRUG TESTING/PHARMACOGENOMICS, BY COUNTRY,  2018-2025 (USD MILLION)
    9.7 HIV/AIDS
        TABLE 89 IVD MARKET FOR HIV/AIDS, BY COUNTRY, 2018-2025 (USD MILLION)
    9.8 AUTOIMMUNE DISEASES
        TABLE 90 IVD MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
    9.9 NEPHROLOGY
        TABLE 91 IVD MARKET FOR NEPHROLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
    9.10 OTHER APPLICATIONS
        TABLE 92 IVD MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)

10 IN VITRO DIAGNOSTICS MARKET, BY END USER (Page No. - 167)
     10.1 INTRODUCTION
          TABLE 93 IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
     10.2 HOSPITAL LABORATORIES
          TABLE 94 IVD MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2018-2025 (USD MILLION) 
     10.3 CLINICAL LABORATORIES
          TABLE 95 IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2018-2025 (USD MILLION)
          TABLE 96 IVD MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2018-2025 (USD MILLION)
             10.3.1 LARGE/REFERENCE LABORATORIES
                    TABLE 97 LARGE/REFERENCE LABORATORIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
             10.3.2 MEDIUM-SIZED LABORATORIES
                    TABLE 98 MEDIUM-SIZED LABORATORIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
             10.3.3 SMALL LABORATORIES
                    TABLE 99 SMALL LABORATORIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
     10.4 POINT-OF-CARE TESTING
          TABLE 100 IVD MARKET FOR POC TESTING, BY COUNTRY, 2018-2025 (USD MILLION)
     10.5 PATIENT SELF-TESTING
          TABLE 101 IVD MARKET FOR PATIENT SELF-TESTING, BY COUNTRY, 2018-2025 (USD MILLION)
     10.6 ACADEMIC INSTITUTES
          TABLE 102 IVD MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
     10.7 OTHER END USERS
          TABLE 103 IVD MARKET FOR OTHER END USERS, BY COUNTRY, 2018-2025 (USD MILLION)

11 IN VITRO DIAGNOSTICS MARKET, BY REGION (Page No. - 178)
     11.1 INTRODUCTION
          TABLE 104 IVD MARKET, BY REGION, 2018-2025 (USD MILLION)
     11.2 NORTH AMERICA
          FIGURE 29 NORTH AMERICA: IVD MARKET SNAPSHOT
          TABLE 105 NORTH AMERICA: IVD MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
          TABLE 106 NORTH AMERICA: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
          TABLE 107 NORTH AMERICA: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
          TABLE 108 NORTH AMERICA: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
          TABLE 109 NORTH AMERICA: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
          TABLE 110 NORTH AMERICA: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
          TABLE 111 NORTH AMERICA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
             11.2.1 US
                    TABLE 112 US: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 113 US: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
                    TABLE 114 US: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 115 US: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
                    TABLE 116 US: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 117 US: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
             11.2.2 CANADA
                    TABLE 118 CANADA: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 119 CANADA: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
                    TABLE 120 CANADA: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 121 CANADA: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
                    TABLE 122 CANADA: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 123 CANADA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
     11.3 EUROPE
          FIGURE 30 EUROPE: IVD MARKET SNAPSHOT
          TABLE 124 EUROPE: IVD MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
          TABLE 125 EUROPE: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
          TABLE 126 EUROPE: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
          TABLE 127 EUROPE: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
          TABLE 128 EUROPE: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
          TABLE 129 EUROPE: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
          TABLE 130 EUROPE: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2018-2025 (USD MILLION)
             11.3.1 GERMANY
                    TABLE 131 GERMANY: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 132 GERMANY: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
                    TABLE 133 GERMANY: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 134 GERMANY: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
                    TABLE 135 GERMANY: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 136 GERMANY: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
             11.3.2 FRANCE
                    TABLE 137 FRANCE: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 138 FRANCE: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
                    TABLE 139 FRANCE: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 140 FRANCE: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
                    TABLE 141 FRANCE: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 142 FRANCE: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
             11.3.3 UK
                    TABLE 143 UK: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 144 UK: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
                    TABLE 145 UK: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 146 UK: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
                    TABLE 147 UK: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 148 UK: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
             11.3.4 ITALY
                    TABLE 149 ITALY: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 150 ITALY: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
                    TABLE 151 ITALY: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 152 ITALY: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
                    TABLE 153 ITALY: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 154 ITALY: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
             11.3.5 SPAIN
                    TABLE 155 SPAIN: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 156 SPAIN: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
                    TABLE 157 SPAIN: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 158 SPAIN: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
                    TABLE 159 SPAIN: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 160 SPAIN: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
             11.3.6 RUSSIA
                    TABLE 161 RUSSIA: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 162 RUSSIA: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
                    TABLE 163 RUSSIA: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 164 RUSSIA: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
                    TABLE 165 RUSSIA: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 166 RUSSIA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
             11.3.7 REST OF EUROPE
                    TABLE 167 ROE: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 168 ROE: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
                    TABLE 169 ROE: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 170 ROE: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
                    TABLE 171 ROE: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 172 ROE: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
     11.4 ASIA PACIFIC
          FIGURE 31 ASIA PACIFIC: IVD MARKET SNAPSHOT
          TABLE 173 ASIA PACIFIC: IVD MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
          TABLE 174 ASIA PACIFIC: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
          TABLE 175 ASIA PACIFIC: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
          TABLE 176 ASIA PACIFIC: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
          TABLE 177 ASIA PACIFIC: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
          TABLE 178 ASIA PACIFIC: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
          TABLE 179 ASIA PACIFIC: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
             11.4.1 JAPAN
                    TABLE 180 JAPAN: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 181 JAPAN: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
                    TABLE 182 JAPAN: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 183 JAPAN: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
                    TABLE 184 JAPAN: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 185 JAPAN: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
             11.4.2 CHINA
                    TABLE 186 CHINA: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 187 CHINA: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
                    TABLE 188 CHINA: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 189 CHINA: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
                    TABLE 190 CHINA: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 191 CHINA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
             11.4.3 INDIA
                    TABLE 192 INDIA: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 193 INDIA: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
                    TABLE 194 INDIA: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 195 INDIA: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
                    TABLE 196 INDIA: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 197 INDIA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,2018-2025 (USD MILLION)
             11.4.4 SOUTH KOREA
                    TABLE 198 SOUTH KOREA: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 199 SOUTH KOREA: IVD INSTRUMENTS MARKET, BY TYPE,2018-2025 (USD MILLION)
                    TABLE 200 SOUTH KOREA: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 201 SOUTH KOREA: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
                    TABLE 202 SOUTH KOREA: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 203 SOUTH KOREA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2018-2025 (USD MILLION)
             11.4.5 INDONESIA
                    TABLE 204 INDONESIA: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 205 INDONESIA: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
                    TABLE 206 INDONESIA: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 207 INDONESIA: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
                    TABLE 208 INDONESIA: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 209 INDONESIA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
             11.4.6 REST OF ASIA PACIFIC
                    TABLE 210 ROAPAC: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 211 ROAPAC: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
                    TABLE 212 ROAPAC: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 213 ROAPAC: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
                    TABLE 214 ROAPAC: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 215 ROAPAC: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
     11.5 LATIN AMERICA
          TABLE 216 LATIN AMERICA: IVD MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
          TABLE 217 LATIN AMERICA: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
          TABLE 218 LATIN AMERICA: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
          TABLE 219 LATIN AMERICA: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
          TABLE 220 LATIN AMERICA: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
          TABLE 221 LATIN AMERICA: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
          TABLE 222 LATIN AMERICA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
             11.5.1 BRAZIL
                    TABLE 223 BRAZIL: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 224 BRAZIL: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
                    TABLE 225 BRAZIL: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 226 BRAZIL: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
                    TABLE 227 BRAZIL: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 228 BRAZIL: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
             11.5.2 MEXICO
                    TABLE 229 MEXICO: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 230 MEXICO: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
                    TABLE 231 MEXICO: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 232 MEXICO: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
                    TABLE 233 MEXICO: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 234 MEXICO: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
             11.5.3 REST OF LATIN AMERICA
                    TABLE 235 ROLA: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 236 ROLA: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
                    TABLE 237 ROLA: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 238 ROLA: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
                    TABLE 239 ROLA: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 240 ROLA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2018-2025 (USD MILLION)
     11.6 MIDDLE EAST & AFRICA
          TABLE 241 MIDDLE EAST & AFRICA: IVD MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
          TABLE 242 MIDDLE EAST & AFRICA: IVD MARKET, BY PRODUCT & SERVICE,  2018-2025 (USD MILLION)
          TABLE 243 MIDDLE EAST & AFRICA: IVD INSTRUMENTS MARKET, BY TYPE,  2018-2025 (USD MILLION)
          TABLE 244 MIDDLE EAST & AFRICA: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
          TABLE 245 MIDDLE EAST & AFRICA: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
          TABLE 246 MIDDLE EAST & AFRICA: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
          TABLE 247 MIDDLE EAST & AFRICA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
             11.6.1 SAUDI ARABIA
                    TABLE 248 SAUDI ARABIA: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 249 SAUDI ARABIA: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
                    TABLE 250 SAUDI ARABIA: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 251 SAUDI ARABIA: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 252 SAUDI ARABIA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)
             11.6.2 REST OF MIDDLE EAST & AFRICA (ROMEA)
                    TABLE 253 ROMEA: IVD MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
                    TABLE 254 ROMEA: IVD INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
                    TABLE 255 ROMEA: IVD MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
                    TABLE 256 ROMEA: IVD MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
                    TABLE 257 ROMEA: IVD MARKET, BY END USER, 2018-2025 (USD MILLION)
                    TABLE 258 ROMEA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018-2025 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 244)
     12.1 INTRODUCTION
          FIGURE 32 KEY DEVELOPMENTS IN THE IVD MARKET
     12.2 COMPETITIVE EVALUATION MATRIX
             12.2.1 STARS
             12.2.2 EMERGING LEADERS
             12.2.3 PERVASIVE PLAYERS
             12.2.4 PARTICIPANTS
                    FIGURE 33 IVD MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
     12.3 MARKET SHARE ANALYSIS
          FIGURE 34 GLOBAL IN VITRO DIAGNOSTICS MARKET SHARE ANALYSIS,  BY KEY PLAYER (2019)
             12.3.1 MARKET SHARE ANALYSIS, BY TECHNOLOGY
                       12.3.1.1 Clinical chemistry
                                FIGURE 35 GLOBAL CLINICAL CHEMISTRY MARKET SHARE ANALYSIS,  BY KEY PLAYER (2019)
                       12.3.1.2 Immunochemistry/immunoassay analyzers
                                FIGURE 36 GLOBAL IMMUNOASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER (2019)
                       12.3.1.3 Clinical microbiology systems
                                FIGURE 37 GLOBAL MICROBIOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER (2019)
                       12.3.1.4 Molecular diagnostics
                                FIGURE 38 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS,  BY KEY PLAYER (2019)
                       12.3.1.5 Hematology
                                FIGURE 39 GLOBAL HEMATOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER (2019)
                       12.3.1.6 Clinical coagulation analyzers
                                FIGURE 40 GLOBAL CLINICAL COAGULATION ANALYZERS MARKET SHARE ANALYSIS,  BY KEY PLAYER (2019)
     12.4 COMPETITIVE SITUATION AND TRENDS
             12.4.1 PRODUCT LAUNCHES & APPROVALS
                    TABLE 259 PRODUCT LAUNCHES & APPROVALS
             12.4.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
                    TABLE 260 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
             12.4.3 ACQUISITIONS
                    TABLE 261 ACQUISITIONS
             12.4.4 EXPANSIONS
                    TABLE 262 EXPANSIONS

13 COMPANY PROFILES (Page No. - 255)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
     13.1 ROCHE DIAGNOSTICS
          FIGURE 41 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2019)
     13.2 DANAHER CORPORATION
          FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
     13.3 ABBOTT LABORATORIES, INC.
          FIGURE 43 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
     13.4 SIEMENS HEALTHINEERS
          FIGURE 44 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2019)
     13.5 SYSMEX CORPORATION
          FIGURE 45 SYSMEX CORPORATION: COMPANY SNAPSHOT (2019)
     13.6 THERMO FISHER SCIENTIFIC
          FIGURE 46 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2016)
     13.7 BECTON, DICKINSON AND COMPANY
          FIGURE 47 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
     13.8 BIOMÉRIEUX SA
          FIGURE 48 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2019)
     13.9 BIO-RAD LABORATORIES, INC.
          FIGURE 49 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)
     13.1 JOHNSON & JOHNSON
          FIGURE 50 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2019)
     13.11 AGILENT TECHNOLOGIES
          FIGURE 51 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019)
     13.12 QIAGEN
          FIGURE 52 QIAGEN: COMPANY SNAPSHOT (2019)
     13.13 DIASORIN
          FIGURE 53 DIASORIN: COMPANY SNAPSHOT (2019)
     13.14 ORTHO CLINICAL DIAGNOSTICS (A PART OF CARLYLE GROUP)
     13.15 SPEEDX DIAGNOSTICS
     13.16 GENSPEED BIOTECH GMBH
     13.17 GENOMEME
     13.18 ACCELERATE DIAGNOSTICS, INC.
     13.19 MSDX
     13.20 CARIS LIFE SCIENCES, INC.

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

14 APPENDIX (Page No. - 348)
     14.1 DISCUSSION GUIDE
     14.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
     14.3 AVAILABLE CUSTOMIZATIONS
     14.4 RELATED REPORTS
     14.5 AUTHOR DETAILS

This study involved the extensive use of both primary and secondary sources. The research process included a study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies. 

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the in vitro diagnostics market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research. 

Primary Research

In the primary research process, industry experts from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Industry experts from the supply side include CEOs, presidents, vice presidents, marketing managers, product managers, sales executives, business development executives, and technology & innovation directors of companies providing in vitro diagnostics as well as key opinion leaders in IVD companies, medical device companies, and CROs. A breakdown of primary respondents is provided below: 

In-Vitro Diagnostics Market Size

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends by type and end user). 

Data Triangulation

After arriving at the market size, the total in vitro diagnostics market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. 

Objectives of the Study

  • To define, describe, and forecast the in vitro diagnostics market by products and services, technology, application, end user, and region.
  • To provide detailed information about the key factors influencing market growth (such as drivers, opportunities, restraints, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overallin vitro diagnostics market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of thein vitro diagnostics market in five main regions (along with major countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East, and Africa
  • To profile key players in the in vitro diagnostics market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as mergers and acquisitions; service launches; expansions; collaborations and agreements; and R&D activities of the leading players in the in vitro diagnostics market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players
COVID-19

Get in-depth analysis of the COVID-19 impact on the In-Vitro Diagnostics Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the In-Vitro Diagnostics Market

Request For Special Pricing
Report Code
MD 3609
Published ON
Nov, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the In-Vitro Diagnostics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home